Authors/Disclosures
|
|
No disclosure on file |
|
Lucia Galan Davila, MD
|
Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Dr. Galan Davila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for pfizer. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. Dr. Galan Davila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sobi. The institution of Dr. Galan Davila has received research support from Alnylam. |
|
Francesc R. Graus, MD
(IDIBAPS)
|
Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
Alvaro Vela Souto, DO
(Lundbeck Espana, S.A.)
|
No disclosure on file |
|
Charles Wira
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Carlos Otavio Brandao, MD, PhD
(Neurolife)
|
No disclosure on file |